Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Kenmare expects non-cash impairment from revised pricing assumptions

(Sharecast News) - Kenmare Resources said in an update on Wednesday that it expects to book a non-cash impairment charge of up to $125m in its half-year results, citing revised long-term pricing assumptions due to an uncertain market outlook for titanium feedstocks. However, the miner said the charge would not affect operations, projects, financing, or its ability to pay dividends.

The London-listed company, which operates the Moma titanium minerals mine in northern Mozambique, reported a 5% year-on-year increase in heavy mineral concentrate (HMC) production to 358,300 tonnes in the second quarter, as higher ore grades offset a decline in excavated volumes.

Ilmenite production rose 3% to 245,400 tonnes, while shipments fell 23% to 181,800 tonnes due to adverse weather and vessel maintenance.

"Kenmare continued to experience consistent demand for all of its products in the second quarter, with ilmenite prices remaining stable during the first half, and we have a strong order book for H2," said managing director Tom Hickey.

"However, uncertainty regarding market conditions in the medium term has led us to slightly lower our long-term pricing assumptions.

"While this is disappointing, it will be a non-cash charge with no anticipated impact on our operations, projects or financing facilities or the company's ability to pay dividends."

Kenmare reaffirmed its full-year production and cost guidance, with higher second-half output expected as new dredges come online as part of the $341m upgrade of Wet Concentrator Plant A.

Commissioning of the upgraded plant remains on track for later in the third quarter.

The company also confirmed it had been added to the FTSE4Good Index Series and maintained its dividend policy, guiding for an interim payout of between eight and 12 US cents per share.

It said it was planning to disregard the impairment charge in determining its full-year dividend.

As at 30 June, net debt stood at $83.1m, up from $25m at the end of 2024, reflecting capital investment and the final 2024 dividend payment.

Kenmare said it expected net debt to remain elevated until the second half of 2026, when free cash flow was forecast to increase.

Kenmare said its first half results would be published on 20 August.

At 1254 BST, shares in Kenmare Resources were down 2.93% at 315.47p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.